Radiofrequency ablation for hepatocellular carcinoma: A survival analysis of 117 patients

ANZ Journal of Surgery

Volumn 80, Issue 10, 2010, Pages 714-721

  Li, Wing Hong ^a   Ma, Ka Wing ^a   Cheng, Mina ^a   Chui, King Him ^a   Chan, Pat Tat ^a   Chu, Wai Ho ^a   Fung, Hon Shing ^a   Kowk, Chong Hei ^a   Cheung, Moon Tong ^a  

^a QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

Hepatocellular carcinoma; Radiofrequency ablation; Survival

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; AGED; ARTICLE; CATHETER ABLATION; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LENGTH OF STAY; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MIDDLE AGED; MORTALITY; PROGNOSIS; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LENGTH OF STAY; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; TREATMENT OUTCOME;

EID: 78650504830     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2010.05434.x     Document Type: Article

References (39)

1. El-Serag HB. Hepatocellular carcinoma: an epidemiologic view. J. Clin. Gastroenterol. 2002; 35(Suppl. 2): S72-8.
2. Hong Kong Cancer Registry. Untitled. Hospital Authority, 2006.
3. Curley SA. Radiofrequency ablation of malignant liver tumors. Ann. Surg. Oncol. 2003; 10: 338-47.
4. Li W-H, Cheung M-T. Recurrence and survival for hepatocellular carcinoma after curative resection: tertiary centre experience. Surg. Pract. 2008; 12: 45-50.
5. Goldberg SN, Grassi CJ, Cardella JF et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. J. Vasc. Interv. Radiol. 2005; 16: 165-78.
6. Gervais DA, Goldberg SN, Brown DB, Soulen MC, Millward SF, Rajan DK; Interventional Oncology Task Force and Standards Division, Society of Interventional Radiology. Society of Interventional Radiology position statement on percutaneous radiofrequency ablation for the treatment of liver tumors. J. Vasc. Interv. Radiol. 2009; 20: 3-8.
7. Chen MS, Li JQ, Zheng Y et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann. Surg. 2006; 243: 321-8.
8. Poon D, Anderson BO, Chen L-T et al. Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol. 2009; 10: 1111-8.
9. Crocetti L, De Baere T, Lencioni R. Quality improvement guidelines for radiofrequency ablation of liver tumours. Cardiovasc. Intervent. Radiol. 2010; 33: 11-7.
10. N'Kontchou G, Mahamoudi A, Aout M et al. Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis. Hepatology 2009; 50: 1475-83.
11. Guglielmi A, Ruzzenente A, Battocchia A, Tonon A, Fracastoro G, Cordiano C. Radiofrequency ablation of hepatocellular carcinoma in cirrhotic patients. Hepatogastroenterology 2003; 50: 480-4.
12. Livraghi T, Goldberg SN, Lazzaroni S et al. Hepatocellular carcinoma: radiofrequency ablation of medium and large lesions. Radiology 2000; 214: 761-8.
13. Poon RT, Ng KK, Lam CM, Ai V, Yuen J, Fan ST. Effectiveness of radiofrequency ablation for hepatocellular carcinomas larger than 3 cm in diameter. Arch. Surg. 2004; 139: 281-7.
14. Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, Michel L. Local recurrences after hepatic radiofrequency (RF) coagulation. Multivariate meta-analysis and review of contributing factors. Ann. Surg. 2005; 242: 158-71.
15. Khan MR, Poon RTP, Ng KK et al. Comparison of percutaneous and surgical approaches for radiofrequency ablation of small and medium hepatocelullar carcinoma. Arch. Surg. 2007; 142: 1136-43.
16. Burdio F, Mulier S, Navarro A et al. Influence of approach on outcome in radiofrequency ablation of liver tumors. Surg Oncol 2008; 17: 295-9.
17. Fernandes ML, Lin C-C, Lin C-J, Chen W-T, Lin S-M. Risk of tumour progression in early-stage hepatocellular carcinoma after radiofrequency ablation. Br. J. Surg. 2009; 96: 756-62.
18. Guglielmi A, Ruzzenente A, Sandri M, Pachera S, Pedrazzani C. Radio frequency ablation for hepatocellular carcinoma in cirrhotic patients: prognostic factors for survival. J. Gastrointest. Surg. 2007; 11: 143-9.
19. Ng KK, Poon RT, Lo C-M, Yuen J, Tso WK, Fan ST. Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma. J. Gastrointest. Surg. 2008; 12: 183-91.
20. Yamane B, Weber S. Liver-directed treatment modalities for primary and secondary hepatic tumors. Surg. Clin. North Am. 2009; 89: 97-113.
21. Cha CH, Saif MW, Yamane BH, Weber SM. Hepatocellular carcinoma: current management. Curr. Probl. Surg. 2010; 47: 10-67.
22. Scaife CL, Curley SA. Complication, local recurrence, and survival rates after radiofrequency ablation for hepatic malignancies. Surg. Oncol. Clin. N. Am. 2003; 12: 243-55.
23. De Baere T, Risse O, Kuoch V et al. Adverse effects during radiofrequency treatment of 582 hepatic tumors. Am. J. Roentgenol. 2003; 181: 695-700.
24. Poon RT, Ng KK, Lam CM et al. Learning curve for radiofrequency ablation of liver tumors: prospective analysis of initial 100 patients in a tertiary institution. Ann. Surg. 2004; 239: 441-9.
25. Wong J, Lee KF, Lee PSF et al. Radiofrequency ablation for 110 malignant liver tumours: preliminary results on percutaneous and surgical approaches. Asian J. Surg. 2009; 32: 13-20.
26. Wah TM, Arellano RS, Gervais DA et al. Image-guided percutaneous radiofrequency ablation and incidence of post-radiofrequency ablation syndrome: prospective survey. Radiology 2005; 237: 1097-102.
27. Curley SA, Izzo F, Ellis LM, Vauthey JN, Vallone P. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann. Surg. 2000; 232: 381-91.
28. Llovet JM, Vilana R, Bru C et al. Barcelona Clinic Liver Cancer (BCLC) Group. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 2001; 33: 1124-9.
29. Bolondi L, Gaiani S, Celli N, Piscaglia F. Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma. Hepatology 2001; 34: 608.
30. De Sio I, Castellano L, De Girolamo V et al. Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma. Hepatology 2001; 34: 609-10.
31. Goldberg SN, Solbiati L. Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma. Hepatology 2001; 34: 609.
32. Camma C, Di Marco V, Orlando A et al. Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study. J. Hepatol. 2005; 42: 535-40.
33. Montorsi M, Santambrogio R, Bianchi P et al. Survival and recurrences after hepatic resection or radiofrequency for hepatocellular carcinoma in cirrhotic patients: a multivariate analysis. J. Gastrointest. Surg. 2005; 9: 62-7.
34. Berber E, Rogers S, Siperstein A. Predictors of survival after laparoscopic radiofrequency thermal ablation of hepatocellular cancer: a prospective study. Surg. Endosc. 2005; 19: 710-4.
35. Tateishi R, Shiina S, Teratani T et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 2005; 103: 1201-9.
36. Tangkijvanich P, Anukulkarnkusol N, Suwangool P et al. Clinical characteristics and prognosis of hepatocellular carcinoma: analysis based on serum alpha-fetoprotein levels. J. Gastrointest. Surg. 2000; 31: 302-8.
37. Zytoon AA, Ishii H, Murakami K et al. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome. Jpn. J. Clin. Oncol. 2007; 37: 658-72.
38. Kim YS, Rhim H, Cho OK, Koh BH, Kim Y. Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carci-noma: analysis of the pattern and risk factors. Eur. J. Radiol. 2006; 59: 432-41.
39. Yu H-C, Cheng J-S, Lai K-H, Lin C-P, Lo G-H. Factors for early tumor recurrence of single small hepatocellular carcinoma after percutaneous radiofrequency ablation therapy. World J. Gastroenterol. 2005; 11: 1439-44.